Fibromyalgia Syndrome Clinical Trial
— KAFAOfficial title:
Kontrollierte Klinische Nicht-randomisierte Pilotstudie Zur Komplexen Āyurveda-Therapie Beim Fibromyalgiesyndrom im Vergleich Zur Konventionellen Standardbehandlung
| Verified date | May 2013 |
| Source | Charite University, Berlin, Germany |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Germany: Ethics Committee |
| Study type | Observational |
The aim of this study is to evaluate the effectiveness of an additive complex āyurvedic diagnosis and treatment compared to conventional standard care alone in stationary patients with Fibromyalgia Syndrome.
| Status | Completed |
| Enrollment | 31 |
| Est. completion date | May 2013 |
| Est. primary completion date | May 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - informed consent - age between 18 and 70 years - FMS according to current guidelines Exclusion Criteria: - change of pharmacological FMS treatment >= 6 weeks before inclusion - pregnancy or breat feeding - acute psychiatric condition - severe acute somatic disease - severechronic comorbidity - obesity WHO >= II degree - bloodcoagulation-disease - intake of opiods - current treatment with hyperthermia - simultaneous participant in other trial - praticipation in other trial during 6 month before inclusion |
Observational Model: Case Control, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Germany | Immanuel Hospital Berlin | Berlin |
| Lead Sponsor | Collaborator |
|---|---|
| Andreas Michalsen | Dr.Heinz Horst Deichmann Foundation,Essen,Germany |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Fibromyalgia Impact Questionnaire (FIQ) | Change in FIQ after completion of IPD-treatment | max. 3 weeks | No |
| Secondary | Functional Hanover Questionnaire (FFBH) | max. 3 weeks | No | |
| Secondary | State Trait Anxiety Inventory (STAI) | max. 3 weeks | No | |
| Secondary | Profile of Mood States (POMS) | max. 3 weeks | No | |
| Secondary | Short Form 36 Health Survey (SF-36) | max. 3 weeks | No | |
| Secondary | VAS for pain | max 3 weeks | No | |
| Secondary | Likert-Scales | max 3 weeks | No | |
| Secondary | FIQ | 6 month | No | |
| Secondary | FFBH, STAI, POMS, SF-36, VAS, Likert-Scales. | 6 month | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05933486 -
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
|
Phase 4 | |
| Completed |
NCT01642810 -
Online Acceptance-based Behavioural Treatment for Fibromyalgia
|
Phase 3 | |
| Completed |
NCT00757679 -
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
|
Phase 2 | |
| Completed |
NCT00757731 -
FMS European Long-Term Study
|
Phase 3 | |
| Completed |
NCT01968772 -
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
|
N/A | |
| Completed |
NCT00401830 -
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
|
Phase 2 | |
| Completed |
NCT04517929 -
Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT06285045 -
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
|
N/A | |
| Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 | |
| Completed |
NCT02800720 -
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome
|
N/A | |
| Not yet recruiting |
NCT01465477 -
Influenza Vaccination in Fibromyalgia Patients
|
N/A | |
| Completed |
NCT00528710 -
Efficacy of S-Adenosylmethionine in Fibromyalgia
|
Phase 2 | |
| Completed |
NCT00447083 -
Benefits of Tanning in Fibromyalgia Patients
|
N/A | |
| Not yet recruiting |
NCT06147882 -
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
| Completed |
NCT00464737 -
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
|
Phase 2 | |
| Completed |
NCT04426864 -
Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.
|
N/A | |
| Completed |
NCT02881411 -
Self Soft Tissue Therapy for Fibromyalgia Syndrome
|
N/A | |
| Not yet recruiting |
NCT01147263 -
Palpitations and Tachycardia in Fibromyalgia Syndrome
|
N/A | |
| Completed |
NCT00222274 -
HRV Biofeedback in Fibromyalgia
|
N/A |